跳至主要内容
临床试验/NCT05698030
NCT05698030已完成不适用

Efficacy of Oral Immunotherapy to Pistachio in Children on the Oral Tolerance to Pistachio and Cashew Nuts

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Absence of moderate to severe allergic reactions

研究概览

简要总结

The objectives of this study are (i) to evaluate the efficacy of oral immunotherapy to pistachio by evaluating the daily oral tolerance of 2g pistachio, by evaluating the long-term tolerance of 15g pistachio (sustained unresponsiveness) and by decreasing pistachio-specific IgE, (ii) evaluating the efficacy of pistachio immunotherapy on cashew tolerance, (iii) and to evaluate the safety of pistachio immunotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients under 18 years of age with a proven allergy to pistachio and followed in the pediatric allergology unit of the Nancy University Hospital.
  • Patients who have received oral immunotherapy to pistachio for at least 18 months at 31/12/2022

排除标准

  • Patients who have received oral immunotherapy to pistachio for less than 18 months.
  • Patients lost to follow-up for more than 2 years or last consultation dating from 2020 or earlier

结局指标

主要结局

Absence of moderate to severe allergic reactions

时间窗: during the 6 months of maintenance

with daily intake of 2g of pistachio

次要结局

  • Frequency and severity of allergic reactions(during the dose escalation phase and during the maintenance phase (first 6 months, 1st year, 2nd year, 3rd year))
  • Decrease in specific IgE and increase of IGg4 to pistachio(during the dose escalation phase and during the maintenance phase (first 6 months, 1st year, 2nd year, 3rd year))
  • Tolerance of 1, 2, 4, 8g in isolated doses and 15 g in total cumulative dose of pistachio(3 months after stopping daily consumption of 2g pistachio)
  • Tolerance of 1, 2, 4, 8g in isolated doses and 15 g in total cumulative dose of cashew nut(3 months after stopping daily consumption of 2g pistachio)
  • Reactogenic or tolerogenic threshold of cashew nuts(during the dose escalation phase and during the maintenance phase (first 6 months, 1st year, 2nd year, 3rd year))

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

Amandine DIVARET-CHAUVEAU

MCU-PH

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验